Krebs Biochemicals & Industries Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2025 ,inter alia, to consider and approve The Company ....
KREBSBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Krebs Biochemicals & Industries has informed the stock exchanges that its Board of Directors will meet on Tuesday, November 4, 2025. The main item on the agenda is to consider and approve the unaudited financial results for the second quarter (July–September 2025) and the half year ended September 30, 2025. The filing is a standard disclosure under SEBI's Listing Regulations, made by the Company Secretary on October 16, 2025. The trading window for insiders has already been closed since September 30, 2025, and will reopen 48 hours after the results are announced.
This is a routine compliance intimation with no direct impact on the stock. Investors should watch the November 4, 2025 results announcement for actual earnings performance and any management commentary that may move the stock.